Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: The Leiden 85-Plus Study

American Journal of Clinical Nutrition

Volumn 82, Issue 4, 2005, Pages 866-871

  Mooijaart, Simon P ^a   Gussekloo, Jacobijn ^a   Frölich, Marijke ^a   Jolles, Jelle ^b   Stott, David J ^c   Westendorp, Rudi G J ^a   De Craen, Anton J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cognitive decline; Elderly persons; Folic acid; Homocysteine; Vitamin B 12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AGED; AGING; AMINO ACID BLOOD LEVEL; ARTICLE; COGNITION; COGNITIVE DEFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; VITAMIN BLOOD LEVEL; BLOOD; CROSS-SECTIONAL STUDY; DEMENTIA; LONGITUDINAL STUDY; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RISK FACTOR; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; AGING; COGNITION; CROSS-SECTIONAL STUDIES; DEMENTIA; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN B 12;

EID: 27744461645     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/82.4.866     Document Type: Article

References (31)

1. Pennypacker LC, Allen RH, Kelly JP, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc 1992;40:1197-204.
2. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;5:1143-53.
3. Kawas CH. Early Alzheimer's disease. N Engl J Med 2003;49:1056-63.
4. de Fourniere LF, Ferry M, Cnockaet X, et al. Deicience en vitamine B12 et etat dementiel etude epidemiologique multicentrique et therapeutique essai preliminaire. [Vitamin B12 deficiency and dementia: a multicenter epidemiologic and therapeutic study.] Semaine des Hopitaux 1997;73: 133-40(in French).
5. Seal EC, Metz J, Flicker L, Melny J. A randomized double blind placebo controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations. J Am Geriatr Soc 2002;50:146-51.
6. Fioravanti M, Ferrario E, Massaia M, et al. Low folate levels in the cognitive decline of elderly patients and efficacy of folate as a treatment for improving memory deficits. Arch Gerontol Geriatr 1997;26:1-13.
7. Sommer BR, Hoff AL, Costa M. Folic acid supplementation in dementia: a preliminary report. J Geriatr Psychiatry Neurol 2003;16:156-9.
8. Bryan J, Calvaresi E, Hughes D. Short term folate, vitamin B12 or vitamin B6 supplementation slightly affects memory performance but not mood in women of various ages. J Nutr 2002;132:1345-56.
9. Clarke R, Harrison G, Richards S, VITAL Trial Collaborative Group. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med 2003;254:67-75.
10. Malouf R, Grimley Evans J, Areosa Sastre A. Folic acid with or without vitamin B12 for cognition and dementia (Cochrane Review). In: The Cochrane Library. Issue 3. Chichester, United Kingdom: Wiley & Sons, Ltd, 2004.
11. Malouf R, Areosa Sastre A. Vitamin B12 for cognition (Cochrane Review). In: The Cochrane Library. Issue 3. Chichester, United Kingdom: Wiley & Sons, Ltd, 2004.
12. Prins ND, den Heijer T, Hofman A, et al. Homocysteine and cognitive function in the elderly. The Rotterdam Study. Neurology 2002;59:1375-80.
13. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-83.
14. Hutto BR. Folate and cobalamin in psychiatric illness. Comp Psychiatry 1997;6:305-14.
15. Bootsma-van der Wiel A, van Exel E, de Craen AJM, et al. A high response is not essential to prevent selection bias: results from the Leiden 85-plus Study. J Clin Epidemiol 2002;55:1119-25.
16. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
17. Houx PJ, Shepherd J, Blauw GJ, et al. Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk. J Neurol Neurosurg Psychiatry 2002;73: 385-9.
18. Moller JT, Cluitmans P, Rasmussen LS, et al. Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 1998;351:857-61.
19. de Craen AJM, Heeren TJ, Gussekloo J. Accuracy of the 15-item Geriatric Depression Scale (GDS-15) in a community sample of the oldest old. Int J Geriatr Psychiatry 2003;18:63-6.
20. Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 2004;61:310-7.
21. Crystal HA, Ortof E, Frishman WH, Gruber A, Hershman D, Aronson M. Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 1995;43:1065-6.
22. Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology 2001;56:1188-94.
23. Martin DC, Francis J, Protetch J, et al. Time dependency of cognitive recovery with cobalamin replacement: a report of a pilot study. J Am Geriatr Soc 1992;40:168-72.
24. Meadows ME, Kaplan RF, Bromfield EB. Cognitive recovery with vitamin B12 therapy: a longitudinal neuropsychological assessment. Neurology 1994;44:1764-5.
25. van Asselt DZ, Pasman JW, van Lier HJ, et al. Cobalamin supplementation improves cognitive and cerebral function in older, cobalamin-deficient persons. J Gerontol A Biol Sci Med Sci 2001;56:M775-9.
26. Eastley R, Wilcock GK, Bucks RS. Vitamin B12 deficiency in dementia and cognitive impairment: the effects of treatment on neuropsychological function. Int J Geriatr Psychiatry 2000;15:226-33.
27. Teunisse S, Bollen AE, van Gool WA, Walstra GJ. Dementia and subnormal levels of vitamin B12: effects of replacement therapy on dementia. J Neurol 1996;243:522-9.
28. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449-55.
29. McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001;12:309-13.
30. Dufouil C, Alperovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003;53:214-21.
31. Andersen K, Launer LJ, Dewey ME, et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999;53:1992-7.